ANGELI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 17.035
AS - Asia 11.271
EU - Europa 9.897
SA - Sud America 2.208
Continente sconosciuto - Info sul continente non disponibili 480
AF - Africa 313
OC - Oceania 127
Totale 41.331
Nazione #
US - Stati Uniti d'America 16.584
RU - Federazione Russa 3.665
CN - Cina 3.075
SG - Singapore 2.942
IT - Italia 2.760
BR - Brasile 1.772
HK - Hong Kong 1.345
VN - Vietnam 1.233
KR - Corea 1.052
PL - Polonia 902
IE - Irlanda 806
FR - Francia 426
IN - India 424
BD - Bangladesh 387
SE - Svezia 336
DE - Germania 327
CA - Canada 266
FI - Finlandia 249
AR - Argentina 171
ID - Indonesia 171
GB - Regno Unito 155
JP - Giappone 147
AU - Australia 121
EC - Ecuador 84
MX - Messico 81
TR - Turchia 80
IQ - Iraq 64
UA - Ucraina 64
JO - Giordania 62
ZA - Sudafrica 57
NG - Nigeria 53
NL - Olanda 52
CO - Colombia 50
PY - Paraguay 41
ES - Italia 40
MA - Marocco 37
EG - Egitto 33
SA - Arabia Saudita 33
CI - Costa d'Avorio 32
PK - Pakistan 32
VE - Venezuela 32
UZ - Uzbekistan 27
AE - Emirati Arabi Uniti 26
BJ - Benin 25
CL - Cile 25
CH - Svizzera 24
IR - Iran 21
PH - Filippine 21
TW - Taiwan 20
CR - Costa Rica 17
UY - Uruguay 15
BE - Belgio 14
JM - Giamaica 14
CZ - Repubblica Ceca 13
HN - Honduras 13
KE - Kenya 13
MY - Malesia 13
DZ - Algeria 12
SN - Senegal 12
TT - Trinidad e Tobago 12
AZ - Azerbaigian 11
PE - Perù 11
AL - Albania 10
AT - Austria 10
GT - Guatemala 10
OM - Oman 9
TH - Thailandia 9
DO - Repubblica Dominicana 8
LB - Libano 8
MU - Mauritius 8
NP - Nepal 8
TN - Tunisia 8
PS - Palestinian Territory 7
LT - Lituania 6
NZ - Nuova Zelanda 6
PA - Panama 6
PT - Portogallo 6
SV - El Salvador 6
AO - Angola 5
BO - Bolivia 5
DK - Danimarca 5
ET - Etiopia 5
KG - Kirghizistan 5
KH - Cambogia 5
KZ - Kazakistan 5
QA - Qatar 5
RO - Romania 5
NI - Nicaragua 4
PR - Porto Rico 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BH - Bahrain 3
IL - Israele 3
MN - Mongolia 3
RS - Serbia 3
SY - Repubblica araba siriana 3
BG - Bulgaria 2
Totale 40.815
Città #
Santa Clara 3.322
Ashburn 2.595
Singapore 2.258
Fairfield 1.290
Hong Kong 1.094
Seoul 1.045
Hefei 992
Warsaw 894
Dublin 796
Woodbridge 622
Milan 619
San Jose 598
Council Bluffs 555
Seattle 513
Houston 488
Beijing 466
Cambridge 453
Ho Chi Minh City 419
Wilmington 400
Moscow 385
Los Angeles 318
Chandler 308
Altamura 302
Lawrence 296
Lauterbourg 263
The Dalles 259
Rome 255
Hanoi 230
Ann Arbor 226
Mumbai 204
Florence 200
Buffalo 186
Dallas 181
Princeton 181
Munich 169
Helsinki 151
New York 140
Kent 139
Tokyo 135
São Paulo 126
Paris 118
Melbourne 115
Boston 114
Jakarta 103
Medford 93
Dong Ket 81
Shanghai 81
Naples 77
San Diego 74
Boardman 70
Clifton 63
Chicago 60
Turin 57
Da Nang 56
Toronto 53
Abuja 52
Bengaluru 52
Figino 51
Haiphong 49
Delhi 45
Lappeenranta 45
Rio de Janeiro 44
Phoenix 43
London 42
Redondo Beach 40
Washington 38
Orem 37
Frankfurt am Main 36
Guangzhou 36
Bologna 35
Norwalk 35
Porto Alegre 35
Turku 35
Brasília 34
Montreal 34
West Jordan 34
Abidjan 32
Belo Horizonte 32
Hillsboro 32
Miano 32
Falls Church 30
Bari 29
Guayaquil 29
Hải Dương 28
Quito 28
Atlanta 27
Brooklyn 26
Redwood City 26
Biên Hòa 25
Cotonou 25
Curitiba 24
Johannesburg 24
Palermo 24
Philadelphia 24
Tashkent 24
Venice 23
Yubileyny 23
Genoa 22
Guarulhos 22
Istanbul 22
Totale 26.773
Nome #
New Histamine-Related Five-Membered N-Heterocycle Derivatives as Carbonic Anhydrase I Activators 309
Ionic liquids as an alternative reaction medium for HMDST based synthesis of thioaldehydes 277
Synthesis and biological evaluation of cyclic imides incorporating benzenesulfonamide moieties as carbonic anhydrase I, II, IV and IX inhibitors. 277
Heterocoumarins Are Selective Carbonic Anhydrase IX and XII Inhibitors with Cytotoxic Effects against Cancer Cells Lines 270
Synthesis of a new series of 3-functionalised-1-phenyl-1,2,3-triazole sulfamoylbenzamides as carbonic anhydrase I, II, IV and IX inhibitors 265
1,3-Dipolar Cycloaddition, HPLC Enantioseparation, and Docking Studies of Saccharin/Isoxazole and Saccharin/Isoxazoline Derivatives as Selective Carbonic Anhydrase IX and XII Inhibitors 261
Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-Induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX) 238
Design, Synthesis, and X-ray of Selenides as New Class of Agents for Prevention of Diabetic Cerebrovascular Pathology 236
Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII 232
2-(2-Hydroxyethyl)piperazine derivatives as potent human carbonic anhydrase inhibitors: Synthesis, enzyme inhibition, computational studies and antiglaucoma activity 232
1,2,4-Triazole-based anticonvulsant agents with additional ROS scavenging activity are effective in a model of pharmacoresistant epilepsy 230
3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold to Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII 230
Design, synthesis and human carbonic anhydrase I, II, IX and XII inhibitory properties of 1,3-thiazole sulfonamides 227
Discovery of New Selenoureido Analogues of 4-(4-Fluorophenylureido)benzenesulfonamide as Carbonic Anhydrase Inhibitors 217
Synthesis and carbonic anhydrase activating properties of a series of 2-amino-imidazolines structurally related to clonidine 217
Design, synthesis and X-ray crystallography of selenides bearing benzenesulfonamide moiety with neuropathic pain modulating effects. 216
Chalcogenides-incorporating carbonic anhydrase inhibitors concomitantly reverted oxaliplatin-induced neuropathy and enhanced antiproliferative action 214
Syntesis of thio- and seleno-acetamides bearing benzenesulfonamide as potent inhibitors of human carbonic anhydrase II and XII 213
Activation of β- and γ-carbonic anhydrases from pathogenic bacteria with tripeptides 212
Activation studies with amines and amino acids of the β-carbonic anhydrase encoded by the Rv3273 gene from the pathogenic bacterium Mycobacterium tuberculosis 209
Evaluation of selenide, diselenide and selenoheterocycle derivatives as carbonic anhydrase I, II, IV, VII and IX inhibitors 207
Carbonic anhydrase inhibition with sulfonamides incorporating pyrazole-and pyridazinecarboxamide moieties provides examples of isoform-selective inhibitors 204
Investigation of piperazines as human carbonic anhydrase I, II, IV and VII activators 203
From random to rational: A discovery approach to selective subnanomolar inhibitors of human carbonic anhydrase IV based on the Castagnoli-Cushman multicomponent reaction 203
Activation Effects of Carnosine- and Histidine-Containing Dipeptides on Human Carbonic Anhydrases: A Comprehensive Study 203
Activation studies of the α- and β-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae with amines and amino acids 200
Carbonic anhydrase inhibitors based on sorafenib scaffold: Design, synthesis, crystallographic investigation and effects on primary breast cancer cells 198
Synthesis and evaluation of carbonic anhydrase inhibitors with carbon monoxide releasing properties for the management of rheumatoid arthritis 197
Evaluation of Thio- and Seleno-Acetamides Bearing Benzenesulfonamide as Inhibitor of Carbonic Anhydrases from Different Pathogenic Bacteria 194
Antimalarial Agents Targeting Plasmodium falciparum Carbonic Anhydrase: Towards Artesunate Hybrid Compounds with Dual Mechanism of Action 190
Mechanisms of the Antiproliferative and Antitumor Activity of Novel Telomerase-Carbonic Anhydrase Dual-Hybrid Inhibitors 190
CARBAMOSELENOYL DERIVATIVES AS ANTI-INFECTIVE AGENTS 189
First evaluation of organotellurium derivatives as carbonic anhydrase I, II, IV, VII and IX inhibitors 188
Direct and Straightforward access to substituted alkyl selenols as novel carbonic anhydrase inhibitors 188
N-aryl-N’-ureido-O-sulfamates: Potent and selective inhibitors of the human Carbonic Anhydrase VII isoform with neuropathic pain relieving properties 186
Anion inhibition profile of the β-carbonic anhydrase from the opportunist pathogenic fungus malassezia restricta involved in dandruff and seborrheic dermatitis 186
Sulfur, selenium and tellurium containing amines act as effective carbonic anhydrase activators 183
New β-arylchalcogeno amines with procognitive properties targeting Carbonic Anhydrases and Monoamine Oxidases 182
Acyl selenoureido benzensulfonamides show potent inhibitory activity against carbonic anhydrases from the pathogenic bacterium Vibrio cholerae 181
Synthesis of novel 4-functionalized 1,5-diaryl-1,2,3-triazoles containing benzenesulfonamide moiety as carbonic anhydrase I, II, IV and IX inhibitors 180
Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases 179
Activation studies of the γ-carbonic anhydrases from the antarctic marine bacteria pseudoalteromonas haloplanktis and colwellia psychrerythraea with amino acids and amines 177
2-Mercaptobenzoxazoles: a class of carbonic anhydrase inhibitors with a novel binding mode to the enzyme active site 176
Benzenesulfonamide decorated dihydropyrimidin(thi)ones: carbonic anhydrase profiling and antiproliferative activity 174
Azidothymidine "clicked" into 1,2,3-Triazoles: First Report on Carbonic Anhydrase-Telomerase Dual-Hybrid Inhibitors 174
Microwave-assisted extraction, HPLC analysis, and inhibitory effects on carbonic anhydrase I, II, VA, and VII isoforms of 14 blueberry Italian cultivars 173
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 173
Inhibitors of Mitochondrial Human Carbonic Anhydrases VA and VB as a Therapeutic Strategy against Paclitaxel-Induced Neuropathic Pain in Mice 172
Sulfonamide inhibition studies of an α-carbonic anhydrase from Schistosoma mansoni, a platyhelminth parasite responsible for schistosomiasis 172
Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitors 171
Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold 170
A structure-based approach towards the identification of novel antichagasic compounds: Trypanosoma cruzi carbonic anhydrase inhibitors 169
Glycomimetic Based Approach toward Selective Carbonic Anhydrase Inhibitors 169
Benzylaminoethyureido-Tailed Benzenesulfonamides: Design, Synthesis, Kinetic and X-ray Investigations on Human Carbonic Anhydrases 169
Discovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches 168
Inhibition of the α-carbonic anhydrase from Vibrio cholerae with amides and sulfonamides incorporating imidazole moieties 165
In Silico-Guided Identification of New Potent Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae 163
Synthesis of different thio-scaffolds bearing sulfonamide with subnanomolar carbonic anhydrase II and IX inhibitory properties and X-ray investigations for their inhibitory mechanism 163
Polypharmacology of epacadostat: A potent and selective inhibitor of the tumor associated carbonic anhydrases IX and XII 163
Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes 163
Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Management of Rheumatoid Arthritis 161
A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction 160
Discovery of new 2, 5-disubstituted 1,3-selenazoles as selective human carbonic anhydrase IX inhibitors with potent anti-tumor activity 160
Activation studies of the β-carbonic anhydrases from Malassezia restricta with amines and amino acids 160
Activation studies with amines and amino acids of the β-carbonic anhydrase from the pathogenic protozoan Leishmania donovani chagasi 159
Synthesis of novel tellurides bearing benzensulfonamide moiety as carbonic anhydrase inhibitors with antitumor activity 159
New Dihydrothiazole Benzensulfonamides: Looking for Selectivity toward Carbonic Anhydrase Isoforms I, II, IX, and XII 159
Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides 159
Multitargeting application of proline-derived peptidomimetics addressing cancer-related human matrix metalloproteinase 9 and carbonic anhydrase II 158
3-Functionalised benzenesulphonamide based 1,3,4-oxadiazoles as selective carbonic anhydrase XIII inhibitors: Design, synthesis and biological evaluation 157
Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors 157
Synthesis of Azasugar–Sulfonamide conjugates and their Evaluation as Inhibitors of Carbonic Anhydrases: the Azasugar Approach to Selectivity 157
Synthesis and exploration of 2-morpholino-4-phenylthiazol-5-yl acrylamide derivatives for their effects against carbonic anhydrase I, II, IX and XII isoforms as a non-sulfonamide class of inhibitors 157
Synthesis and Biological Evaluation of 4-sulfamoylphenyl/sulfocoumarin carboxamides as selective inhibitors of carbonic anhydrase isoforms hCA II, IX and XII 157
Calixarenes Incorporating Sulfonamide Moieties: Versatile Ligands for Carbonic Anhydrases Inhibition 157
Synthesis of Novel Selenides Bearing Benzenesulfonamide Moieties as Carbonic Anhydrase I, II, IV, VII, and IX Inhibitors 156
Selenols: a new class of carbonic anhydrase inhibitors 156
Activation studies with amines and amino acids of the α-carbonic anhydrase from the pathogenic protozoan Trypanosoma cruzi 156
Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl/1,3,4-thiadiazol-2-yl)-4-(3-substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors 154
Fluoroenesulphonamides: N-sulphonylurea isosteres showing nanomolar selective cancer-related transmembrane human carbonic anhydrase inhibition 154
Tail approach synthesis of novel benzenesulfonamides incorporating 1,3,4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes 154
Glyco-Coated CdSe/ZnS Quantum Dots as Nanoprobes for Carbonic Anhydrase IX Imaging in Cancer Cells 154
Synthesis, characterization, biological assays and development of new enzyme modulators for the treatment of human pathologies 153
Synthesis, Computational Studies and Assessment of in Vitro Activity of Squalene Derivatives as Carbonic Anhydrase Inhibitors 153
Study of Chalcogen Aspirin Derivatives with Carbonic Anhydrase Inhibitory Properties for Treating Inflammatory Pain 152
X-ray crystallography of Epacadostat in adduct with Carbonic Anhydrase IX 152
One-Pot Procedure for the Synthesis of Asymmetric Substituted Ureido Benzene Sulfonamides as Effective Inhibitors of Carbonic Anhydrase Enzymes 152
Benzoselenoates: A novel class of carbonic anhydrase inhibitors 152
Synthesis, biological activity and multiscale molecular modeling studies for coumaryl-carboxamide derivatives as selective carbonic anhydrase IX inhibitors 150
Discovery of a novel series of indolylchalcone-benzenesulfonamide hybrids acting as selective carbonic anhydrase II inhibitors 149
Perfluoroalkyl Substances of Significant Environmental Concern Can Strongly Inhibit Human Carbonic Anhydrase Isozymes 149
Looking toward the Rim of the Active Site Cavity of Druggable Human Carbonic Anhydrase Isoforms 148
Synthesis, computational studies and assessment of in vitro inhibitory activity of umbelliferon-based compounds against tumour-associated carbonic anhydrase isoforms IX and XII 147
Exploring new structural features of the 4-[(3-methyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzenesulphonamide scaffold for the inhibition of human carbonic anhydrases 147
Intramolecular oxidative deselenization of acylselenoureas: a facile synthesis of benzoxazole amides and carbonic anhydrase inhibitors 146
Amine-and amino acid-based compounds as carbonic anhydrase activators 146
Carbonic Anhydrase inhibitors bearing organotelluride moieties as novel agents for antitumor therapy 145
Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases II and VII and show neuropathic pain attenuating effects 144
Sulfonamide Inhibition Profile of the β-Carbonic Anhydrase from Malassezia restricta, An Opportunistic Pathogen Triggering Scalp Conditions 143
Activation of the β-carbonic anhydrase from the protozoan pathogen Trichomonas vaginalis with amines and amino acids 142
Totale 18.168
Categoria #
all - tutte 127.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.596


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.120 0 46 94 68 29 98 53 113 87 66 115 351
2022/20232.702 299 715 98 56 105 414 316 78 307 155 104 55
2023/20241.751 24 90 311 125 108 242 50 343 59 207 147 45
2024/202510.261 391 1.152 613 1.345 2.664 1.347 279 424 598 370 473 605
2025/202618.569 1.392 2.402 2.271 2.435 1.350 489 1.604 952 1.161 1.127 1.240 2.146
2026/20271.313 747 566 0 0 0 0 0 0 0 0 0 0
Totale 41.331